Cargando…

Screening for colon cancer

Colorectal cancer screening reduces mortality in individuals 50 years and older. Each of the screening tests currently available has advantages and limitations, and there is no consensus as to which test or combination of tests is best. What is clear, however, is that the rates of colorectal cancer...

Descripción completa

Detalles Bibliográficos
Autor principal: Heiken, J P
Formato: Texto
Lenguaje:English
Publicado: e-MED 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1805055/
https://www.ncbi.nlm.nih.gov/pubmed/17114066
http://dx.doi.org/10.1102/1470-7330.2006.9026
_version_ 1782132464578199552
author Heiken, J P
author_facet Heiken, J P
author_sort Heiken, J P
collection PubMed
description Colorectal cancer screening reduces mortality in individuals 50 years and older. Each of the screening tests currently available has advantages and limitations, and there is no consensus as to which test or combination of tests is best. What is clear, however, is that the rates of colorectal cancer screening remain low. This review summarizes the clinical evidence supporting colorectal cancer screening in the average risk population and in high risk groups, discusses the advantages and disadvantages of the available screening tests, outlines the currently recommended guidelines for screening based on risk category, and discusses new and emerging technologies for colorectal cancer screening.
format Text
id pubmed-1805055
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher e-MED
record_format MEDLINE/PubMed
spelling pubmed-18050552008-10-31 Screening for colon cancer Heiken, J P Cancer Imaging Article Colorectal cancer screening reduces mortality in individuals 50 years and older. Each of the screening tests currently available has advantages and limitations, and there is no consensus as to which test or combination of tests is best. What is clear, however, is that the rates of colorectal cancer screening remain low. This review summarizes the clinical evidence supporting colorectal cancer screening in the average risk population and in high risk groups, discusses the advantages and disadvantages of the available screening tests, outlines the currently recommended guidelines for screening based on risk category, and discusses new and emerging technologies for colorectal cancer screening. e-MED 2006-10-31 /pmc/articles/PMC1805055/ /pubmed/17114066 http://dx.doi.org/10.1102/1470-7330.2006.9026 Text en Copyright © 2006 International Cancer Imaging Society
spellingShingle Article
Heiken, J P
Screening for colon cancer
title Screening for colon cancer
title_full Screening for colon cancer
title_fullStr Screening for colon cancer
title_full_unstemmed Screening for colon cancer
title_short Screening for colon cancer
title_sort screening for colon cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1805055/
https://www.ncbi.nlm.nih.gov/pubmed/17114066
http://dx.doi.org/10.1102/1470-7330.2006.9026
work_keys_str_mv AT heikenjp screeningforcoloncancer